255 related articles for article (PubMed ID: 25494645)
1. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.
Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ
Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.
Singh PK; Doig CL; Dhiman VK; Turner BM; Smiraglia DJ; Campbell MJ
J Steroid Biochem Mol Biol; 2013 Jul; 136():258-63. PubMed ID: 23098689
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
Sepulveda VA; Weigel NL; Falzon M
Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
[TBL] [Abstract][Full Text] [Related]
5. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
[TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
7. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.
Thorne JL; Maguire O; Doig CL; Battaglia S; Fehr L; Sucheston LE; Heinaniemi M; O'Neill LP; McCabe CJ; Turner BM; Carlberg C; Campbell MJ
Nucleic Acids Res; 2011 Mar; 39(6):2045-56. PubMed ID: 21088000
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
10. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells.
Wang WL; Chatterjee N; Chittur SV; Welsh J; Tenniswood MP
Mol Cancer; 2011 May; 10():58. PubMed ID: 21592394
[TBL] [Abstract][Full Text] [Related]
12. African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A.
Siddappa M; Hussain S; Wani SA; White J; Tang H; Gray JS; Jafari H; Wu HC; Long MD; Elhussin I; Karanam B; Wang H; Morgan R; Hardiman G; Adelani IB; Rotimi SO; Murphy AR; Nonn L; Davis MB; Kittles RA; Hughes Halbert C; Sucheston-Campbell LE; Yates C; Campbell MJ
Cancer Res Commun; 2023 Apr; 3(4):621-639. PubMed ID: 37082578
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
14. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.
Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L
J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352
[TBL] [Abstract][Full Text] [Related]
16. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic corruption of VDR signalling in malignancy.
Abedin SA; Banwell CM; Colston KW; Carlberg C; Campbell MJ
Anticancer Res; 2006; 26(4A):2557-66. PubMed ID: 16886664
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
19. The vitamin D receptor regulates miR-140-5p and targets the MAPK pathway in bone development.
Luo W; Liu L; Yang L; Dong Y; Liu T; Wei X; Liu D; Gu H; Kong J; Yuan Z; Zhao Q
Metabolism; 2018 Aug; 85():139-150. PubMed ID: 29604361
[TBL] [Abstract][Full Text] [Related]
20. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]